Interaction of brain cannabinoid receptors with guanine nucleotide binding protein. A radioligand binding study

Biochemical Pharmacology

Volumn 54, Issue 11, 1997, Pages 1267-1270

  Petitet, François ^a,b   Jeantaud, Bernadette ^a   Capet, Marc ^a   Doble, Adam ^a  

^a SANOFI   (France)

^b CRVA   (France)

Author keywords

Cannabinoid; CP55940; G protein; GTP S; SR141716A; WIN55212 2

Indexed keywords

11 HYDROXYDRONABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); METHANANDAMIDE; RIMONABANT; TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBELLUM; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RADIOLIGAND ASSAY; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0030709362     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00384-5     Document Type: Article

References (17)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI, Structure of a cannahinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
2. Gérard CM, Mollereau C, Vassart G and Parmentier M, Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279: 129-134, 1991.
3. Howlett AC and Fleming RM, Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell memhranes. Mol Pharmacol 26: 532-538, 1984.
4. Bidaut-Russell M, Devane WA and Howlett AC, Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem 55: 21-26, 1990.
5. Devane WA, Dysarz FA, Johnson MR, Melvin LS and Howlett AC, Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613, 1988.
6. Compton DR, Rice KC, de Costa BR, Razdan RK, Melvin LS, Johnson MR and Martin BR, Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218-226, 1993.
7. Kuster JE, Stevenson JI, Ward SJ, D'Ambra TE and Haycock DA, Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J Pharmacol Exp Ther 264: 1352-1363, 1993.
8. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC and Le Fur G, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244, 1994.
9. 3H]SR141716A. Neuro Report 7: 789-792, 1996.
10. 1) cannabinoid receptor antagonist, in rodent brain. Life Sci 58: 1239-1247, 1996.
11. Hirst RA, Almond SL and Lambert DG, Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist. Neurosci Lett 220: 101-104, 1996.
12. 35S]thio)triphosphate binding. Mol Pharmacol 44: 115-123, 1993.
13. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47: 848-854, 1995.
14. 35S]thio]-triphosphate binding. Proc Natl Acad Sci USA 92: 7242-7246, 1995.
15. 35S]thio)triphosphate binding in rat brain membranes. Life Sci 59: 659-668, 1996.
16. 1 cannabinoid receptor. International Cannabinoid Research Symposium p. 66, 1996.
17. 3H]SR141716A. International Cannabinoid Research Symposium p. 37, 1996.